Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan acute respiratory) seropositivity

Circulation

Volumn 103, Issue 10, 2001, Pages 1390-1395

  Sander, Dirk ^a   Winbeck, Kerstin ^b   Klingelhöfer, Jürgen ^a   Etgen, Thorleif ^b   Conrad, Bastian ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Technical University of Munich ^*

Author keywords

Atherosclerosis; Cardiovascular diseases; Carotid arteries; Chlamydia pneumoniae

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; COMMON CAROTID ARTERY; DISEASE COURSE; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0035853023     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.10.1390     Document Type: Article

References (26)

1. Infection and inflammation as risk factors for myocardial infarction
2. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
3. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque
4. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: The West Birmingham Stroke Project
5. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis
6. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: A prospective study in middle-aged to elderly men with treated hypertension
7. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
8. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial infection with Chlamydia (ACADEMIC) study
9. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: The final report of the ROXIS Study
10. Chlamydia pneumoniae eradication from carotid plaques: Results of an open, randomised treatment study
11. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery
12. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults
13. The microimmunofluorescence test for Chlamydia pneumoniae infection: Technique and interpretation
14. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis
15. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST)
16. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study
17. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year folIow-up study
18. Diurnal systolic blood pressure variability is the strongest predictor of early carotid atherosclerosis
19. Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis
20. Chlamydia pneumoniae seropositivity is associated with carotid artery intima-media thickness
21. Chlamydia pneumoniae and atherosclerosis
22. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis
23. Chlamydia pneumoniae in atheroma: Consideration of criteria for causality
24. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
25. Infections, inflammation, and the risk of coronary heart disease
26. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women